<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04957654</url>
  </required_header>
  <id_info>
    <org_study_id>04-21-13</org_study_id>
    <nct_id>NCT04957654</nct_id>
  </id_info>
  <brief_title>Vestibular Socket Therapy in Immediate Implants With Grafting Materials</brief_title>
  <official_title>A Comparative Study Evaluating Vestibular Socket Therapy in Immediate Implants Using Different Grafting Materials</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mohamed Mofreh Hamada Hamed</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current research aims at evaluating the outcomes of the vestibular socket therapy in&#xD;
      immediate implants using collagen plug, demineralized freeze-dried bone allograft, and&#xD;
      deproteinized bovine bone minerals at both radiographic and clinical levels&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 16, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>statistician will be blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>changes in facial plate thickness</measure>
    <time_frame>at baseline, 6 and 12 months</time_frame>
    <description>Each group will be subjected to: Cone beam computed tomography (CBCT) at baseline, 6 months, and 12months to assess the thickness of the labial (facial) plate of bone and implant survival</description>
  </primary_outcome>
  <primary_outcome>
    <measure>changes in facial plate height</measure>
    <time_frame>at baseline, 6 and 12 months</time_frame>
    <description>Each group will be subjected to: Cone beam computed tomography (CBCT) at baseline, 6 months, and 12months to assess height of labial (facial) plate of bone and implant survival</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>changes in peri-implant mucosal level</measure>
    <time_frame>at baseline, 3rd and 6th months</time_frame>
    <description>Each group will be subjected to Intraoral scanning at baseline, 6 months and 12 months. The changes in peri-implant mucosal level will be assessed by superimposition of scanning files of different intervals to monitor the changes in surface area calculated by software.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>Tooth Extraction</condition>
  <condition>Dental Implant</condition>
  <condition>Extarction Socket</condition>
  <arm_group>
    <arm_group_label>VST with collagen plug soaked in blood</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>VST with Allograft Demineralized bone matrix Grafton</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>VST with autogenous cortical chips and bovine deprotinzed particles</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VST with collagen plug soaked in blood</intervention_name>
    <description>-A sub mucoperiosteal tunnel will be created, a membrane shield will be trimmed to fit the facial wall of the socket and introduced through the tunnel lying over the facial bone plate, and the facial gap will be filled with collagen plug soaked in blood</description>
    <arm_group_label>VST with collagen plug soaked in blood</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VST with Allograft Demineralized bone matrix Grafton</intervention_name>
    <description>-A sub mucoperiosteal tunnel will be created, a membrane shield will be trimmed to fit the facial wall of the socket and introduced through the tunnel lying over the facial bone plate, and the facial gap will be filled with Allograft Demineralized bone matrix Grafton</description>
    <arm_group_label>VST with Allograft Demineralized bone matrix Grafton</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>VST with a particulate bone graft composed of two thirds autogenous cortical chips harvested from the surgical site and one third of bovine deprotinzed particles</intervention_name>
    <description>-A sub mucoperiosteal tunnel will be created, a membrane shield will be trimmed to fit the facial wall of the socket and introduced through the tunnel lying over the facial bone plate, and the facial gap will be filled with a particulate bone graft composed of two thirds autogenous cortical chips harvested from the surgical site and one third of bovine deprotinzed particles</description>
    <arm_group_label>VST with autogenous cortical chips and bovine deprotinzed particles</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients will be included if they have one or more hopeless teeth without signs of&#xD;
             acute infection in the maxillary anterior region.&#xD;
&#xD;
          -  Remaining roots or non-restorable teeth with sufficient bone apically and palatably to&#xD;
             allow proper implant positioning with sufficient primary stability.&#xD;
&#xD;
          -  Optimal compliance as evidenced by no missed treatment appointments and a positive&#xD;
             attitude towards oral hygiene.&#xD;
&#xD;
          -  Medically free&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Medically compromised patients and systemic conditions precluding implant and&#xD;
             periodontal surgery.&#xD;
&#xD;
          -  Smokers, diabetics, pregnant or lactating women.&#xD;
&#xD;
          -  History of chemotherapy, radiotherapy in head and/or neck region.&#xD;
&#xD;
          -  Bisphosphonate therapy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mohamed M Hamed, BDS</last_name>
    <phone>01023888701</phone>
    <phone_ext>002</phone_ext>
    <email>mohamedhamed628@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Dentistry, Tanta University</name>
      <address>
        <city>Tanta</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohamed M Hamed, BDS</last_name>
      <phone>01023888701</phone>
      <phone_ext>002</phone_ext>
      <email>mohamedhamed628@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Mohamed M Hamed, BDS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 5, 2021</study_first_submitted>
  <study_first_submitted_qc>July 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2021</study_first_posted>
  <last_update_submitted>July 5, 2021</last_update_submitted>
  <last_update_submitted_qc>July 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Mohamed Mofreh Hamada Hamed</investigator_full_name>
    <investigator_title>clinical researcher</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

